Economy

325 Million Reasons to Buy Netflix Stock Today
Economy

325 Million Reasons to Buy Netflix Stock Today

Netflix (NFLX) continues to dominate the world of storytelling, with the streaming giant recently announcing impressive fourth-quarter 2025 results. The company reported a significant milestone, now boasting 325 million paid…

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

S&P Futures Muted After Record Rally, FOMC Meeting and Earnings in Focus

The December S&P 500 E-Mini futures (ESZ25) are showing a slight decline of -0.02% this morning, following a record-breaking rally.…

Country’s First Venture Fund Officially Launches

Cloud Health EuroVentures, the first venture capital fund in Bosnia and Herzegovina, made its debut this month, marking a significant…

ADP Slips 4% After Reporting Q1 Earnings

Automatic Data Processing Inc. (NASDAQ: ADP) reported strong FY 2026 Q1 earnings that beat expectations, with adjusted EPS at $2.49…

Where Will It Be in 1 Year (Oct 29)

Rivian Automotive Inc. (NASDAQ: RIVN) has been making headlines recently, with shares showing a 4.6% increase over the past week.…

Powell Industries (POWL) Rallied on an Improved, Robust Outlook

Carillon Tower Advisers, an investment management company, recently released its third-quarter 2025 investor letter for the Carillon Eagle Small Cap…

NexPoint Residential raises quarterly dividend 3.9% to 53c per share

NexPoint Residential Trust (NXRT) recently made a significant announcement regarding its dividend payout. The board of directors unanimously approved a…

Boyu Capital is frontrunner for controlling stake in Starbucks China

Boyu Capital Emerges as Top Contender for Starbucks China Stake Acquisition Boyu Capital has positioned itself as the frontrunner in…

Australia’s CSL delays spin-off as US flu vaccine rates decline

CSL Delays Vaccine Division Spin-Off and Cuts Earnings Forecasts By Rishav Chatterjee (Reuters) - Australian biotech company CSL faced a…